Info@ThinkPinkRocks.org

Pharma Major Lupin Limited (Lupin) and Celon Pharma S.A. (Celon) announced today that they have entered into a definitive agreement under which the companies will jointly develop a fluticasone/salmeterol dry powder inhaler (DPI) product which is a generic version of GlaxoSmithKline’s Advair Diskus®.

Visit site:
Celon, Lupin sign definitive agreement to develop generic version of Advair Diskus

Scroll to Top